Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Mixed Results for Adjuvant Pembro in Endometrial Cancer
BARCELONA, Spain — New phase 3 findings revealed that most patients with newly diagnosed high-risk endometrial cancer did not benefit from receiving adjuvant immunotherapy alongside chemotherapy following surgery with curative intent. In the ENGOT-en11/GOG-3053/KEYNOTE-B21 trial, adding pembrolizumab to adjuvant chemotherapy…
English